---
schema_version: "secwatch.filing_event.v1"
accession: "0001401914-26-000010"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-04-17T23:59:59+00:00"
generated_at: "2026-05-15T05:30:06.369606+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Gregory W. Matz reclassified from Class II to Class III director to rebalance board classes

## Summary
- Matz resigned as Class II director and was reappointed as Class III director effective April 16, 2026.
- Reclassification was solely to rebalance the three board classes; service deemed uninterrupted.
- Board remains at six members; Matz and Sabrina Martucci Johnson will stand for election at 2026 annual meeting.
- No changes to Matz's committee assignments as a result of the reclassification.

## SEC filing metadata
- accession: 0001401914-26-000010
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-04-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/0001401914-26-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/dare-20260416.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001401914-26-000010
- JSON: https://secwatch.observer/filing/0001401914-26-000010.json
- Plain text: https://secwatch.observer/filing/0001401914-26-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.